Holen Sie sich die Stockscreener-App
0.77
3.75%
-0.03
Inmed Pharmaceuticals Inc Aktie (INM) Neueste Nachrichten
CEO Moves: Will InMed Pharmaceuticals Inc stock go up in YEAR2026 Review & AI Enhanced Execution Alerts - baoquankhu1.vn
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
InMed Pharmaceuticals Advances INM-901 for Alzheimer’s and INM-089 for Macular Degeneration with FDA Engagement Planned for 2026-2027 1 - Minichart
InMed Pharmaceuticals (INM) Sets 2026 Development Goals - GuruFocus
InMed outlines 2026 development plans for lead programs - TipRanks
InMed Provides 2026 Development Outlook; Targets FDA pre-IND for INM-901 and Phase 1 in 2027 - TradingView
InMed (INM) sets 2026 goals for Alzheimer’s and eye-disease drug programs - Stock Titan
InMed's 2026 push to bring Alzheimer's, eye drug candidates to human testing - Stock Titan
Can InMed Pharmaceuticals Inc reach all time highs this yearJuly 2025 Technicals & Weekly Momentum Picks - baoquankhu1.vn
InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline - Investing News Network
According to the latest filing disclosed by the U.S. Securities and Exchange Commission (SEC), InMed Pharmaceuticals Inc (INM) officially confirmed and passed a resolution on March 4 to gradually terminate the commercial operations of its Baymedica divisio - Bitget
InMed Pharmaceuticals Exits BayMedica to Refocus on Pipeline - TipRanks
U.S. law threat pushes InMed to shut BayMedica unit, pivot to Alzheimer's drugs - Stock Titan
INM Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Can InMed Pharmaceuticals Inc. reach all time highs this yearQuarterly Performance Summary & Technical Confirmation Trade Alerts - mfd.ru
Risk Off: Can InMed Pharmaceuticals Inc be the next market leaderMarket Trend Report & Daily Volume Surge Signals - baoquankhu1.vn
INM Should I Buy - Intellectia AI
Published on: 2026-02-27 15:19:59 - baoquankhu1.vn
Is InMed Pharmaceuticals Inc. undervalued by DCF analysis2025 Bull vs Bear & Safe Capital Growth Stock Tips - mfd.ru
Is InMed Pharmaceuticals Inc. (MWG) stock a contrarian opportunity2025 Market Outlook & Safe Entry Momentum Tips - mfd.ru
INM Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Aug Movers: Is InMed Pharmaceuticals Inc undervalued by DCF analysisMarket Weekly Review & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
InMed Highlights Q2 Results Amid Cash, Regulatory Pressures - TipRanks
InMed Pharmaceuticals Inc Reports Q2 2026 Financial Results and Business Update - TradingView
InMed Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update - Investing News Network
InMed Pharmaceuticals Inc. SEC 10-Q Report - TradingView
What analysts say about InMed Pharmaceuticals Inc. stockJuly 2025 Fed Impact & Verified Stock Trade Ideas - mfd.ru
What drives InMed Pharmaceuticals Inc.’s stock priceGlobal Markets & Verified Entry Point Detection - mfd.ru
Will InMed Pharmaceuticals Inc stock go up in YEAR2025 Key Highlights & Safe Entry Zone Identification - baoquankhu1.vn
Nasdaq Moves: What analysts say about InMed Pharmaceuticals Inc stockTrend Reversal & Growth Focused Investment Plans - baoquankhu1.vn
Can InMed Pharmaceuticals Inc. stock double in the next yearJuly 2025 Fed Impact & Weekly High Conviction Trade Ideas - mfd.ru
Aug Summary: Will InMed Pharmaceuticals Inc. stock go up in YEARJuly 2025 Selloffs & Weekly Chart Analysis and Guides - mfd.ru
Should I add InMed Pharmaceuticals Inc. stock to my portfolio2025 Geopolitical Influence & Weekly High Return Stock Opportunities - mfd.ru
Risk Analysis: What drives InMed Pharmaceuticals Incs stock price2025 Support & Resistance & Momentum Based Trading Ideas - baoquankhu1.vn
InMed faces challenges from new US legislation - MSN
Chart Watch: What analysts say about InMed Pharmaceuticals Inc stockWeekly Trading Summary & Precise Buy Zone Identification - baoquankhu1.vn
Market Catalysts: What analysts say about InMed Pharmaceuticals Inc stockBull Run & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Aug PostEarnings: Does Nano X Imaging Ltd align with a passive investing strategy - baoquankhu1.vn
Performance Recap: Is InMed Pharmaceuticals Inc undervalued by DCF analysisWeekly Profit Analysis & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
Breakout Zone: Can InMed Pharmaceuticals Inc stock surprise with earnings upsideJuly 2025 Big Picture & Safe Capital Investment Plans - Bộ Nội Vụ
Returns Recap: Can InMed Pharmaceuticals Inc. stock beat analyst upgrades2025 Technical Overview & Consistent Profit Alerts - Улправда
Will InMed Pharmaceuticals Inc. (MWG) stock beat revenue estimates2025 Year in Review & Growth Focused Entry Reports - Улправда
Pullback Watch: Can InMed Pharmaceuticals Inc. stock beat analyst upgradesOptions Play & Weekly Watchlist for Hot Stocks - Улправда
What dividend safety score for InMed Pharmaceuticals Inc. stockQuarterly Earnings Review & Budget Friendly Portfolio - Улправда
InMed Pharmaceuticals (NASDAQ:INM) Trading Up 5% – Time to Buy? - Defense World
Indian Infotech and Software Limited At Critical Juncture Bounce or BreakdownGlobal Trade Effects & Budget Friendly Portfolio Growth - earlytimes.in
Risk Check: Can InMed Pharmaceuticals Inc. stock outperform in 2025 bull market - Улправда
Surprises Report: What Wall Street predicts for InMed Pharmaceuticals Inc. stock price2025 Momentum Check & Advanced Technical Analysis Signals - Улправда
Growth Value: Why hedge funds are buying InMed Pharmaceuticals Inc. stock2025 Bull vs Bear & Real-Time Price Movement Reports - Улправда
Can InMed Pharmaceuticals Inc. stock outperform in 2025 bull marketQuarterly Market Summary & Stepwise Trade Signal Implementation - Улправда
Day Trade: How analysts revise price targets for InMed Pharmaceuticals Inc. (MWG) stockJuly 2025 Patterns & Stepwise Entry and Exit Trade Signals - Улправда
Why hedge funds are buying InMed Pharmaceuticals Inc. stockJuly 2025 Trends & Stepwise Entry and Exit Trade Signals - Улправда
InMed Shareholders Approve Directors and Equity Financing Flexibility - TipRanks
InMed Pharmaceuticals (INM) investors approve directors, auditor and 20%+ SEPA share issuance - Stock Titan
InMed Announces Results of 2025 Annual General and Special Meeting - Investing News Network
Drug developer's investors sign off on potential 20% new share issuance - Stock Titan
InMed Pharmaceuticals (INM) director details employee stock option expiry - Stock Titan
InMed Pharmaceuticals (INM) CEO Eric Adams details 250-option expiry - Stock Titan
InMed Pharmaceuticals Inc. (INM) discloses COO stock option expiration - Stock Titan
InMed Pharmaceuticals (INM) reports senior VP employee option expiration - Stock Titan
InMed to Discuss Its Pharmaceutical Pipeline and 2024 Strategic Priorities in Fireside Chat with Water Tower Research on January 25, 2024 at 1pm ET - TMX Newsfile
InMed to Present INM-901 Data at Alzheimer's Association International Conference (AAIC) 2025 - TMX Newsfile
Dated alerts on InMed Pharmaceuticals withdrawn - marketscreener.com
0.66%
1.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):